Latest Security News

EMC Gold has withdrawn its Salave Gold Project’s strategic interest application to strengthen future submissions, while raising €2.64 million from Spanish investors to advance engineering work.

ActivEX Limited has completed a $900,000 placement to fund exploration across its Queensland gold and rare earth element projects, while reporting a cash balance of $98,000 at quarter-end. Key drilling results are awaited as the company progresses multiple tenements and JV discussions.

Avenira Limited has made significant strides in developing its Wonarah Phosphate Project, bolstered by strategic operational appointments and advancing infrastructure plans. Meanwhile, exploration at the Jundee South Gold Project is set to commence in 2026 amid ongoing regulatory challenges.

ECS Botanics Holdings Ltd has seen its ECSO securities suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s next steps.

Aruma Resources has executed binding agreements to acquire a major stake in the Tillex Copper Project in Ontario, complementing strong drilling results from its Australian copper assets and raising $3.5 million to fund exploration.

KALiNA Power has strengthened its financial position by selling a 180 MW load allocation for C$18 million, while advancing its Alberta gas-fired power projects amid evolving regulatory frameworks.

NT Minerals faces ASX trading suspension but pushes forward with exploration plans at Twin Peaks and Finniss River projects, while considering capital restructuring.

MinRex Resources has obtained a crucial ASX waiver allowing it to issue shares to Electrum Discovery shareholders without needing further shareholder approval, smoothing the path for its planned acquisition.

NT Minerals Limited reported a mixed cash flow quarter ending December 2025, with ongoing operational losses offset by strong investing inflows and a solid funding buffer. The company signals confidence in continuing operations despite tight liquidity.

Energy Technologies Limited has significantly improved its cash flow position in the December 2025 quarter, reducing cash outflows by over a third while raising additional debt funding to support working capital.

Immutep Limited has entered a strategic collaboration with Dr. Reddy’s, receiving a A$30 million upfront payment and potential milestones up to A$528 million, while reporting promising clinical progress across multiple cancer immunotherapy trials.

DXN Limited reported a 63% revenue decline in Q2 FY26 due to project delays but bolstered its future outlook with a $15 million backlog and a strategic joint venture in Indonesia.